Zola FE - Search Results

1

Trastuzumab-induced myocardiotoxicity mimicking acute coronary syndrome.

Ribeiro KB, Miranda CH, Andrade JM, Galli LG, Tiezzi DG, Oliveira HF, Zola FE, Volpe G, Pazin-Filho A, Peria FM. Ribeiro KB, et al. Among authors: zola fe. Case Rep Oncol. 2012 Jan;5(1):125-33. doi: 10.1159/000337576. Epub 2012 Mar 17. Case Rep Oncol. 2012. PMID: 22666200 Free PMC article.

2

Breast conserving surgery after neoadjuvant therapy for large primary breast cancer.

Tiezzi DG, Andrade JM, Marana HRC, Zola FE, Peria FM. Tiezzi DG, et al. Among authors: zola fe. Eur J Surg Oncol. 2008 Aug;34(8):863-867. doi: 10.1016/j.ejso.2008.01.015. Epub 2008 Mar 4. Eur J Surg Oncol. 2008. PMID: 18304777

3

HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination.

Tiezzi DG, Andrade JM, Ribeiro-Silva A, Zola FE, Marana HR, Tiezzi MG. Tiezzi DG, et al. Among authors: zola fe. BMC Cancer. 2007 Feb 26;7:36. doi: 10.1186/1471-2407-7-36. BMC Cancer. 2007. PMID: 17324279 Free PMC article.

4

Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy.

Marana HR, de Andrade JM, Dos Reis FJ, Tiezzi DG, Zola FE, Clagnan WS, Garieri AP. Marana HR, et al. Among authors: zola fe. J Surg Oncol. 2009 Nov 1;100(6):505-10. doi: 10.1002/jso.21360. J Surg Oncol. 2009. PMID: 19653248

5

Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients.

Brito LG, de Andrade JM, Lins-Almeida T, Zola FE, Pinheiro MN, Marana HR, Tiezzi DG, Peria FM. Brito LG, et al. Among authors: zola fe. Med Oncol. 2012 Mar;29(1):33-8. doi: 10.1007/s12032-010-9793-8. Epub 2011 Jan 25. Med Oncol. 2012. PMID: 21264546

6

Primary adenocarcinoma of the fallopian tube as an incidental finding during surgery in a postmenopausal patient with unspecific pelvic pain.

Brito LG, Marana HR, de Andrade JM, de Paula Philbert PM, Tiezzi DG, Zola FE. Brito LG, et al. Among authors: zola fe. Eur J Gynaecol Oncol. 2009;30(5):597-9. Eur J Gynaecol Oncol. 2009. PMID: 19899428

7

Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer.

Andrade JM, Carrara HH, Pimentel FF, Marana HR, Macchetti AH, Mouro LR, Zola FE, Tiezzi DG. Andrade JM, et al. Among authors: zola fe. Med Oncol. 2011 Dec;28 Suppl 1:S65-9. doi: 10.1007/s12032-010-9711-0. Epub 2010 Oct 16. Med Oncol. 2011. PMID: 20953738

8

Breast conserving treatment in early breast cancer: impact of local recurrence pattern on patient survival.

Tiezzi DG, de Andrade JM, dos Reis FJ, Melges AC, Zola FE, Marana HR. Tiezzi DG, et al. Among authors: zola fe. Breast J. 2008 Mar-Apr;14(2):215. doi: 10.1111/j.1524-4741.2007.00563.x. Breast J. 2008. PMID: 18315694 No abstract available.

9

Hysteroscopic appearance of malignant and benign endometrial lesions: a case-control study.

Zola FE, Nogueira AA, de Andrade JM, Candido dos Reis FJ. Zola FE, et al. Arch Gynecol Obstet. 2007 Jan;275(1):49-52. doi: 10.1007/s00404-006-0221-4. Epub 2006 Aug 16. Arch Gynecol Obstet. 2007. PMID: 16912853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters